Lilly, an Indianapolis-based drugmaker, plans to build a $3 billion manufacturing plant in the Netherlands to boost ...

U .S. pharmaceutical company Eli Lilly (LLY) has announced plans to build a $3 billion manufacturing plant in the Netherlands ...

The Portland Foundation will hold an open house from 3 to 5 p.m. Thursday, Nov. 6, at John Jay Center for Learning, 101 S. Meridian St., Portland, to celebrate executive director Doug Inman’s 30 years ...

Eli Lilly and Company announced Wednesday, Oct. 29 a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.

Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant ...

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply ...

Eli Lilly plans to build a $3 billion manufacturing facility in the Netherlands to expand its capacity to produce oral medicines. The pharmaceutical company said Monday that the new facility will be ...

Eli Lilly invests $3B in a Netherlands plant to produce obesity drug orforglipron, creating new jobs. Read more here.

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched weight-loss pill, orforglipron, and other ...

Eli Lilly has once again delivered extraordinary financial results, powered by its highly successful diabetes and obesity treatments. The pharmaceutical giant's third-quarter performance has left ...

The facility is expected to produce oral medications, including Lilly's highly anticipated GLP-1 pill for weight loss, orforglipron.

Changes to vaccine recommendations under Health Secretary Robert F. Kennedy Jr. are confusing professionals in the pharmaceutical and insurance industries.